Literature DB >> 2045129

Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis.

K Neuber1, R A Hilger, W König.   

Abstract

The influence of the receptor-specific stimuli interleukin-3 (IL-3), interleukin-8 (IL-8), C5a and formyl-methionyl-leucyl-phenylalanine (FMLP) on the generation of arachidonic acid-derived inflammatory mediators from neutrophils (PMN) has been studied in patients with atopic dermatitis (AD) as well as in healthy, non-atopic volunteers. The release of leukotriene (LT)B4, the omega-oxidation products 20-COOH- and 20-OH-LTB4 and the cysteinyleukotriene LTC4 were measured by reverse-phase HPLC and radioimmunoassay. The incubation of neutrophils with these stimuli led to a significantly higher release of LTB4 and LTC4 in the AD group. The spontaneous leukotriene generation of PMN from patients with AD was on average threefold higher compared to the control group. C5a stimulated the release of LTB4 and its metabolites from atopic cells up to 9 ng in contrast to low amounts from non-atopic cells. Furthermore, FMLP distinctly enhanced the leukotriene release of neutrophils from patients with AD compared to unstimulated cells and to cells of normal donors. IL-3 and IL-8 also significantly stimulated the generation of LTB4 and LTC4 of PMN from atopic patients. Our data emphasize that neutrophils may play an important role in the pathogenesis of AD by an increased responsiveness to receptor-specific stimuli and further suggest that IL-3 and IL-8 influence the acute and chronic inflammatory reactions in patients with AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045129      PMCID: PMC1384522     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Isolation of lymphocytes, granulocytes and macrophages.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1976-06       Impact factor: 3.487

2.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.

Authors:  J M Schröder; U Mrowietz; E Morita; E Christophers
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

Review 3.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

4.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study.

Authors:  V Mielke; J G Bauman; M Sticherling; T Ibs; A G Zomershoe; K Seligmann; H H Henneicke; J M Schröder; W Sterry; E Christophers
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

6.  Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.

Authors:  T Ruzicka; T Simmet; B A Peskar; J Ring
Journal:  J Invest Dermatol       Date:  1986-02       Impact factor: 8.551

7.  Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.

Authors:  T Fukuda; S L Dunnette; C E Reed; S J Ackerman; M S Peters; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1985-11

8.  Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

Authors:  P F Weller; C W Lee; D W Foster; E J Corey; K F Austen; R A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema.

Authors:  T Ruzicka; J Ring
Journal:  Acta Derm Venereol       Date:  1987       Impact factor: 4.437

10.  Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.

Authors:  C A Dahinden; J Zingg; F E Maly; A L de Weck
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  4 in total

1.  Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis.

Authors:  H Okano-Mitani; K Ikai; S Imamura
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

2.  Regulatory effects of cytokine production in atopic allergic reaction by gammi-danguieumja.

Authors:  Ho-Jeong Na; Hye-Young Shin; Na-Hyung Kim; Mi-Won Kwon; Eun-Jeong Park; Seung-Heon Hong; Nam-Il Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

3.  Corticosteroid treatment in cystic fibrosis.

Authors:  J F Price; P Greally
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

4.  The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis.

Authors:  Vassilis Papalazarou; Tong Zhang; Nikki R Paul; Amelie Juin; Marco Cantini; Oliver D K Maddocks; Manuel Salmeron-Sanchez; Laura M Machesky
Journal:  Nat Metab       Date:  2020-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.